Charles River Laboratories International, Inc. · NYSE:CRL
Girshick Birgit sold 6,500 Charles River Laboratories International, Inc. shares (Form 4)
Traded Aug 11, 2026 · Filed Aug 13, 2026
On Aug 11, 2026, Girshick Birgit (Director, Chief Executive Officer) sold 6,500 Charles River Laboratories International, Inc. shares at US$279.90 for US$1.82M under a trading plan, leaving 36,013 shares. Filed Aug 13, 2026 (Form 4).
- Sold
- 6,500 shares
- Price
- US$279.90
- Value
- US$1.82M
- Holding after
- 36,013 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Common Stock | Option exercise | 6,500 | US$179.66 | 42,513 | Direct |
| Aug 11, 2026 | Common Stock | Sale | 6,500 | US$279.90 | 36,013 | Direct |
Source
Related
- Charles River Laboratories International, Inc.
- Girshick Birgit
- Charles River Laboratories International, Inc. shareholders
- Form 4 · Girshick Birgit · Aug 20, 2026
- Form 4 · Girshick Birgit · Jun 8, 2026
- Form 4 · Girshick Birgit · Jun 2, 2026
- Form 4 · Girshick Birgit · May 28, 2026
- Form 4 · Parisotto Shannon M · Oct 7, 2026
- Form 4 · Coleman Glenn · Oct 2, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Form 4 · Foster James C · Aug 27, 2026
- Form 4 · Parisotto Shannon M · Aug 20, 2026